Literature DB >> 15858840

Pharmacokinetic study of methotrexate following intra-articular injection of methotrexate loaded poly(L-lactic acid) microspheres in rabbits.

Linda S Liang1, Wesley Wong, Helen M Burt.   

Abstract

The pharmacokinetics and tissue distribution of methotrexate (MTX) were investigated following intra-articular injection of either MTX solution or controlled release MTX loaded microspheres in healthy rabbit joints. MTX solution or MTX loaded microspheres (size 30-100 mum) (10 mg MTX) was injected into the right knee joint cavity of rabbits. Blood samples were taken at predetermined times from the jugular vein. Urine samples were also collected over time periods up to 24 h. The major organs and synovial tissues were removed for analysis 6 and 24 h post-injection (n = 4). MTX and 7-OH-MTX concentrations in the plasma and major organs were determined by HPLC. The MTX plasma area under the concentration-time curve (AUC) for rabbits injected with MTX solution was seven fold higher than that of the rabbits injected with MTX microspheres, while t(1/2) and mean residence time (MRT) were not significantly different between two treatment groups. Four fold more MTX was excreted in the urine from rabbits injected with MTX solution compared to those injected with MTX loaded microspheres 24 h following intra-articular injection. The concentration of MTX in the synovial tissues following intra-articular injection was significantly higher in the rabbits injected with microspheres than in the rabbits injected with MTX solution. MTX solution was rapidly cleared from the joint cavity while MTX encapsulated microspheres retained MTX in the joint cavity. (c) 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15858840     DOI: 10.1002/jps.20341

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  6 in total

1.  Intra-articular treatment of inflammatory arthritis with microsphere formulations of methotrexate: pharmacokinetics and efficacy determination in antigen-induced arthritic rabbits.

Authors:  Linda S Liang; Paul T Salo; David A Hart; Helen M Burt
Journal:  Inflamm Res       Date:  2009-03-06       Impact factor: 4.575

Review 2.  Progress in intra-articular therapy.

Authors:  Christopher H Evans; Virginia B Kraus; Lori A Setton
Journal:  Nat Rev Rheumatol       Date:  2013-11-05       Impact factor: 20.543

3.  Nanoparticles for improved local retention after intra-articular injection into the knee joint.

Authors:  Michael Morgen; David Tung; Britton Boras; Warren Miller; Anne-Marie Malfait; Micky Tortorella
Journal:  Pharm Res       Date:  2012-09-21       Impact factor: 4.200

4.  Increased localized delivery of piroxicam by cationic nanoparticles after intra-articular injection.

Authors:  Sung Rae Kim; Myoung Jin Ho; Sang Hyun Kim; Ha Ra Cho; Han Sol Kim; Yong Seok Choi; Young Wook Choi; Myung Joo Kang
Journal:  Drug Des Devel Ther       Date:  2016-11-16       Impact factor: 4.162

5.  Magnetically retainable microparticles for drug delivery to the joint: efficacy studies in an antigen-induced arthritis model in mice.

Authors:  Nicoleta Butoescu; Christian A Seemayer; Gaby Palmer; Pierre-André Guerne; Cem Gabay; Eric Doelker; Olivier Jordan
Journal:  Arthritis Res Ther       Date:  2009-05-19       Impact factor: 5.156

6.  Cationic PLGA/Eudragit RL nanoparticles for increasing retention time in synovial cavity after intra-articular injection in knee joint.

Authors:  Sung Rae Kim; Myoung Jin Ho; Eugene Lee; Joon Woo Lee; Young Wook Choi; Myung Joo Kang
Journal:  Int J Nanomedicine       Date:  2015-08-24
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.